Vaccines, blood, antisera, toxins and cultures in   Saudi Arabia

Exports In 2023, Saudi Arabia exported $4.12M in Vaccines, blood, antisera, toxins and cultures, making it the 80th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 421st most exported product in Saudi Arabia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Saudi Arabia are: Kuwait ($1.45M), Bahrain ($843k), Netherlands ($503k), United Arab Emirates ($325k), and United States ($263k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Saudi Arabia between 2022 and 2023 were Kuwait ($1.09M), Netherlands ($481k), and Sudan ($134k).

Imports In 2023, Saudi Arabia imported $1.8B in Vaccines, blood, antisera, toxins and cultures, becoming the 23rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Saudi Arabia. Saudi Arabia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($290M), Germany ($281M), Belgium ($234M), United States ($204M), and Ireland ($173M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Saudi Arabia between 2022 and 2023 were Italy ($92.7M), Jordan ($40.5M), and Switzerland ($37.8M).